Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
De novo sirolimus monotherapy after antithymocyte globulin induction in kidney transplant recipients
DRKS00000858Phase 3Terminated
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of sirolimus in chronic kidney disease (CKD) (2 arms), sponsored by Universitätsklinikum Freiburg. Started Apr 2012; status: terminated.
02
Drugs
sirolimus
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on DRKS00000858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000858.